全球糖尿病護理設備市場
市場調查報告書
商品編碼
1669763

全球糖尿病護理設備市場

Global Diabetic Care Devices Market

出版日期: | 出版商: BCC Research | 英文 103 Pages | 訂單完成後即時交付

價格

全球糖尿病照護設備市場規模預計將從 2024 年的 166 億美元成長到 2029年終的 268 億美元,預測期內(2024-2029 年)的複合年成長率為 10.1%。

全球連續血糖監測 (CGM) 系統市場規模預計將從 2024 年的 111 億美元成長到 2029年終的 209 億美元,預測期內的複合年成長率為 13.4%。此外,全球自我血糖監測 (SMBG) 設備市場規模預計將從 2024 年的 55 億美元成長到 2029年終的 59 億美元,複合年成長率為 1.7%。

本報告調查了全球糖尿病護理設備市場,並提供了市場的全面概述、市場影響因素和市場機會的分析、法律制度、新興技術和技術發展的趨勢、市場規模的趨勢和預測、各個細分市場和地區的詳細分析、競爭格局以及主要企業的概況。

目錄

第1章執行摘要

  • 市場展望
  • 研究範圍
  • 市場概況

第2章 市場概況

  • 市場定義
  • 糖尿病
  • 糖尿病的類型
  • 自我監測糖尿病護理設備

第3章 市場動態

  • 市場動態
  • 市場促進因素
  • 糖尿病盛行率不斷上升
  • 老齡人口不斷增加
  • 對更好、更個人的糖尿病管理工具的需求
  • 醫療保健和報銷政策
  • 重視預防保健
  • 市場限制
  • 缺乏持續資料
  • CGM 的高成本
  • 低收入地區的無障礙限制
  • 市場機會
  • 糖尿病管理解決方案的需求
  • 夥伴關係
  • 市場挑戰
  • 血糖值儀和 CGM 缺乏準確性

第4章 新興科技與發展

  • 概述
  • 植入式連續血糖監測技術
  • CGM 監測中的 AI 整合
  • 非侵入式 CGM 系統
  • 臨床試驗

第5章市場區隔分析

  • 細分市場
  • 全球糖尿病監測設備市場類型
  • 自我監測血糖 (SMBG) 設備
  • 持續血糖監測 (CGM) 系統
  • 地理分佈
  • 全球糖尿病監測設備市場(按區域)
  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 其他地區

第6章 競爭訊息

  • 產業場景
  • 競爭格局

7. 糖尿病護理設備市場的永續性:ESG 視角

  • ESG:簡介
  • ESG績效分析
  • 環境績效
  • 社會績效
  • 管治績效
  • BCC的結語

第 8 章 附錄

  • 調查方法
  • 參考
  • 簡稱
  • 公司簡介
  • ABBOTT
  • ACON LABORATORIES INC.
  • AGAMATRIX
  • ARKRAY INC.
  • B. BRAUN SE
  • DEXCOM INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • I-SENS INC.
  • LIFESCAN IP HOLDINGS LLC.
  • MEDTRONIC
  • PHC HOLDINGS CORP.
  • SENSEONICS
  • SINOCARE
  • TERUMO CORP.
  • YPSOMED
Product Code: MDS019B

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

The global market for continuous glucose monitoring systems is expected to grow from $11.1 billion in 2024 to $20.9 billion by the end of 2029, at a CAGR of 13.4% from 2024 through 2029.

The global market for self-monitoring blood glucose devices is expected to grow from $5.5 billion in 2024 to $5.9 billion by the end of 2029, at a CAGR of 1.7% from 2024 through 2029.

Report Scope

This report provides an analysis of the market for diabetes monitoring devices, along with a competitive landscape and profiles of key companies that include their revenues, product portfolios and recent activities. It analyzes trends and market dynamics, including drivers, limitations, challenges, and opportunities, and discusses historical, current and potential market size. The report will enable readers to make informed decisions about the production and licensing of goods and services, as well as market developments and trends. The study segments the market by product type, including self-monitoring blood glucose (SMBG) devices such as blood glucose meter devices, blood glucose test strips, lancets and lancet devices; and continuous glucose monitoring (CGM) device products, including transmitters and receivers. A regional market analysis, including country-level analysis, is provided for all segments. The report covers only diabetes monitoring devices; diabetes therapeutic devices, which include insulin delivery systems and any other equipment used in hospitals are outside the scope of the report.

Self-monitoring blood glucose (SMBG) devices:

  • Blood glucose meter devices.
  • Blood glucose test strips.
  • Lancets and lancet devices.

Continuous glucose monitoring (CGM) systems:

  • Sensors and transmitters.
  • Receivers.

End users:

  • Hospitals.
  • Home care settings.
  • Diagnostic centers.

Report Includes:

  • 30 data tables and 47 additional tables
  • An analysis of the global market for diabetes care devices, including self-glucose monitoring devices and continuous glucose monitoring systems
  • Analyses of the global market trends, with market revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
  • Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type and sub-type, end user and region
  • Discussion of the market potential and opportunities in the diabetes care industry, along with an analysis of the competitive environment, regulatory scenario and technological advances
  • Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Patent analysis featuring key granted and published patents
  • Emerging new developments and clinical trials in the diabetes care market
  • Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of leading companies, including Abbott, Medtronic, Dexcom Inc., F. Hoffmann-La Roche Ltd., and LifeScan IP Holdings LLC.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Market Definitions
  • Diabetes Mellitus
  • Types of Diabetes
  • Self-Monitoring Diabetic Care Devices

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Increasing Prevalence of Diabetes
  • Increasing Aging Population
  • Demand for Better Personal Diabetes Management Tools
  • Healthcare and Reimbursement Policies
  • Increasing Focus on Preventive Healthcare
  • Market Restraints
  • Lack of Continuous Data
  • High Cost of CGMs
  • Limited Access in Low-Income Regions
  • Opportunities in the Market
  • Need for Diabetes Management Solutions
  • Partnerships
  • Market Challenges
  • Lack of Glucose Meter and CGM Accuracy

Chapter 4 Emerging Technologies and Developments

  • Overview
  • Implantable CGM Technology
  • AI Integration in CGM Monitoring
  • Non-Invasive CGM System
  • Clinical Trials

Chapter 5 Market Segmentation Analysis

  • Segmentation Breakdown
  • Global Market for Diabetes Monitoring Devices, by Type
  • Self-Monitoring Blood Glucose (SMBG) Devices
  • Continuous Glucose Monitoring (CGM) Systems
  • Geographic Breakdown
  • Global Market for Diabetes Monitoring Devices, by Region
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Industry Scenario
  • Competitive Landscape

Chapter 7 Sustainability in the Diabetic Care Devices Market: An ESG Perspective

  • Introduction to ESG
  • ESG Performance Analysis
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks from BCC Research

Chapter 8 Appendix

  • Research Methodology
  • References
  • Abbreviations
  • Company Profiles
  • ABBOTT
  • ACON LABORATORIES INC.
  • AGAMATRIX
  • ARKRAY INC.
  • B. BRAUN SE
  • DEXCOM INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • I-SENS INC.
  • LIFESCAN IP HOLDINGS LLC.
  • MEDTRONIC
  • PHC HOLDINGS CORP.
  • SENSEONICS
  • SINOCARE
  • TERUMO CORP.
  • YPSOMED

List of Tables

  • Summary Table : Global Market for Diabetes Monitoring Devices, by Product Type, Through 2029
  • Table 1 : Blood Glucose Test Strip Manufacturers and Products
  • Table 2 : Blood Glucose Device Products and Manufacturers
  • Table 3 : Blood Glucose Lancets/Lancet Devices Products and Manufacturers
  • Table 4 : CGM Sensor and Transmitter Products and Manufacturers
  • Table 5 : CGM Receiver Products and Manufacturers
  • Table 6 : Diabetes Cases, by Country, 2021
  • Table 7 : Comparison of Eversense, Abbott, Medtronic and Dexcom CGMs
  • Table 8 : Selected Clinical Trials of Diabetic Care Devices
  • Table 9 : Global Market for Diabetes Monitoring Devices, by Type, Through 2029
  • Table 10 : Global Market for SMBG Devices, by Product Type, Through 2029
  • Table 11 : Global Market for CGM Systems, by Product Type, Through 2029
  • Table 12 : Global Market for Diabetes Monitoring Devices, by Region, Through 2029
  • Table 13 : Global Market for SMBG Devices, by Region, Through 2029
  • Table 14 : Global Market for Blood Glucose Test Strips, by Region, Through 2029
  • Table 15 : Global Market for Blood Glucose Meters/Devices, by Region, Through 2029
  • Table 16 : Global Market for Lancets and Lancet Devices, by Region, Through 2029
  • Table 17 : Global Market for CGM Systems, by Region, Through 2029
  • Table 18 : Global Market for Sensors and Transmitters Used in CGM Devices, by Region, Through 2029
  • Table 19 : Global Market for Receivers Used in CGM Devices, by Region, Through 2029
  • Table 20 : Global Market for Diabetes Monitoring Devices, by End User, Through 2029
  • Table 21 : North American Market for Diabetes Monitoring Devices, by Country, Through 2029
  • Table 22 : European Market for Diabetes Monitoring Devices, by Country, Through 2029
  • Table 23 : Asia-Pacific Market for Diabetes Monitoring Devices, by Country, Through 2029
  • Table 24 : South American Market for Diabetes Monitoring Devices, by Country, Through 2029
  • Table 25 : RoW Market for Diabetes Monitoring Devices, Through 2029
  • Table 26 : ESG: Environmental Performance
  • Table 27 : ESG: Social Impact
  • Table 28 : ESG: Governance Impact
  • Table 29 : Acronyms Used in this Report
  • Table 30 : Abbott: Company Snapshot
  • Table 31 : Abbott: Financial Performance, FY 2022 and 2023
  • Table 32 : Abbott: Product Portfolio
  • Table 33 : Abbott: News/Key Developments, 2024
  • Table 34 : Acon Laboratories Inc.: Company Snapshot
  • Table 35 : Acon Laboratories Inc.: Product Portfolio
  • Table 36 : AgaMatrix: Company Snapshot
  • Table 37 : AgaMatrix: Product Portfolio
  • Table 38 : Arkray Inc.: Company Snapshot
  • Table 39 : Arkray Inc.: Product Portfolio
  • Table 40 : B. Braun SE: Company Snapshot
  • Table 41 : B. Braun SE: Financial Performance, FY 2022 and 2023
  • Table 42 : B. Braun SE: Product Portfolio
  • Table 43 : Dexcom Inc.: Company Snapshot
  • Table 44 : Dexcom Inc.: Financial Performance, FY 2022 and 2023
  • Table 45 : Dexcom Inc.: Product Portfolio
  • Table 46 : Dexcom Inc.: News/Key Developments, 2022
  • Table 47 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 48 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
  • Table 49 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 50 : i-SENS Inc.: Company Snapshot
  • Table 51 : i-SENS Inc.: Financial Performance, FY 2022 and 2023
  • Table 52 : i-SENS Inc.: Product Portfolio
  • Table 53 : i-SENS Inc: News/Key Developments, 2023
  • Table 54 : LifeScan IP Holdings LLC.: Company Snapshot
  • Table 55 : LifeScan IP Holdings LLC.: Product Portfolio
  • Table 56 : Medtronic: Company Snapshot
  • Table 57 : Medtronic: Financial Performance, FY 2023 and 2024
  • Table 58 : Medtronic: Product Portfolio
  • Table 59 : Medtronic: News/Key Developments, 2023
  • Table 60 : PHC Holdings Corp.: Company Snapshot
  • Table 61 : PHC Holdings Corp.: Financial Performance, FY 2022 and 2023
  • Table 62 : PHC Holdings Corp.: Product Portfolio
  • Table 63 : Senseonics: Company Snapshot
  • Table 64 : Senseonics: Financial Performance, FY 2022 and 2023
  • Table 65 : Senseonics: Product Portfolio
  • Table 66 : Senseonics: News/Key Developments, 2022
  • Table 67 : Sinocare: Company Snapshot
  • Table 68 : Sinocare: Financial Performance, FY 2022 and 2023
  • Table 69 : Sinocare: Product Portfolio
  • Table 70 : Sinocare: News/Key Developments, 2024
  • Table 71 : Terumo Corp: Company Snapshot
  • Table 72 : Terumo Corp.: Financial Performance, FY 2022 and 2023
  • Table 73 : Terumo Corp: Product Portfolio
  • Table 74 : Ypsomed: Company Snapshot
  • Table 75 : Ypsomed: Financial Performance, FY 2022 and 2023
  • Table 76 : Ypsomed: Product Portfolio

List of Figures

  • Summary Figure A : Global Market for Diabetes Monitoring Devices, by Product Type, 2021-2029
  • Summary Figure B : Share of Global Market for Diabetes Monitoring Devices, by Product Type, 2023
  • Figure 1 : Snapshot of the Market Dynamics for Diabetic Care Devices
  • Figure 2 : Worldwide Diabetes Cases
  • Figure 3 : Emerging Trends and Technologies in Diabetes Monitoring Devices
  • Figure 4 : Share of Global Market for Diabetes Monitoring Devices, by Type, 2023
  • Figure 5 : Share of Global Market for SMBG Devices, by Product Type, 2023
  • Figure 6 : Share of Global Market for CGM Systems, by Product Type, 2023
  • Figure 7 : Share of Global Market for Diabetes Monitoring Devices, by Region, 2023
  • Figure 8 : Share of Global Market for SMBG Devices, by Region, 2023
  • Figure 9 : Share of Global Market for Blood Glucose Test Strips, by Region, 2023
  • Figure 10 : Share of Global Market for Blood Glucose Meters/Devices, by Region, 2023
  • Figure 11 : Share of Global Market for Lancets and Lancet Devices, by Region, 2023
  • Figure 12 : Share of Global Market for CGM Systems, by Region, 2023
  • Figure 13 : Share of Global Market for Sensors and Transmitters Used in CGM Devices, by Region, 2023
  • Figure 14 : Share of Global Market for Receivers Used in CGM Devices, by Region, 2023
  • Figure 15 : Share of North American Market for Diabetes Monitoring Devices, by Country, 2023
  • Figure 16 : Share of European Market for Diabetes Monitoring Devices, by Country, 2023
  • Figure 17 : Share of Asia-Pacific Market for Diabetes Monitoring Devices, by Country, 2023
  • Figure 18 : Share of South American Market for Diabetes Monitoring Devices, by Country, 2023
  • Figure 19 : Share of Global Market for Diabetes Monitoring Devices, by Company, 2023
  • Figure 20 : Three Pillars of ESG
  • Figure 21 : Advantages of ESG for Companies
  • Figure 22 : Abbott: Revenue Share, by Business Unit, FY 2023
  • Figure 23 : Abbott: Revenue Share, by Country/Region, FY 2023
  • Figure 24 : B. Braun SE: Revenue Share, by Business Unit, FY 2023
  • Figure 25 : B. Braun SE: Revenue Share, by Country/Region, FY 2023
  • Figure 26 : Dexcom Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
  • Figure 28 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
  • Figure 29 : i-SENS Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 30 : i-SENS Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 31 : Medtronic: Revenue Share, by Business Unit, FY 2024
  • Figure 32 : Medtronic: Revenue Share, by Country/Region, FY 2024
  • Figure 33 : PHC Holdings Corp.: Revenue Share, by Business Unit, FY 2023
  • Figure 34 : PHC Holdings Corp.: Revenue Share, by Country/Region, FY 2023
  • Figure 35 : Senseonics: Revenue Share, by Country/Region, FY 2023
  • Figure 36 : Sinocare: Revenue Share, by Business Unit, FY 2023
  • Figure 37 : Sinocare: Revenue Share, by Country/Region, FY 2023
  • Figure 38 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023
  • Figure 39 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
  • Figure 40 : Ypsomed: Revenue Share, by Business Unit, FY 2023
  • Figure 41 : Ypsomed: Revenue Share, by Country/Region, FY 2023